What's the potential for bfly new technology given its availability

Butterfly Network, Inc. (NYSE:BFLY) has several potential growth drivers for its new technology:

1. **Expansion of iQ3 Ultrasound Probe**: The successful launch of the iQ3 probe has led to a 55% increase in product revenue year-over-year, indicating strong market acceptance and potential for further growth.
2. **International Market Growth**: Entering new markets in Indonesia, the Netherlands, and Belgium contributed to a 36% increase in international revenue, suggesting a growing global presence.
3. **Formation of Octiv™**: The introduction of Octiv, a subsidiary focused on extending Butterfly's proprietary chip technology, could unlock further value for shareholders and attract new investors.
4. **Butterfly HomeCare Pilot**: The planned launch of a virtual chronic care management pilot with a leading Medicare Advantage provider aims to improve heart failure outcomes through AI-powered imaging, indicating potential in the chronic care market.
5. **Educational and Veterinary Advancements**: Collaborations with Kansas City University and research supporting Butterfly's use in managing bovine respiratory disease in cattle strengthen its role in medical education and veterinary medicine.
6. **Commercial Agreement with Mendaera**: The partnership with Mendaera to commercialize a robotic system powered by Butterfly's Ultrasound-on-Chip™ technology represents a new revenue stream and potential for growth in the robotic intervention market.

Given these developments, Butterfly Network, Inc. is well-positioned to capitalize on its new technology and expand its market reach, driving future growth and innovation in the digital health sector.